Neomycin (topical): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
m (Kiran Singh moved page Neomycin to Neomycin (topical) without leaving a redirect)
 
(18 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
{{DrugProjectFormSinglePage
{{Neomycin}}
|authorTag={{DB}}
{{CMG}}
|genericName=Neomycin
|aOrAn=an
|drugClass=anti- bacterial agent, anti- infective agent
|indicationType=treatment
|indication=[[hepatic encephalopathy]], preoperative preparation of bowel for procedure, prophylaxis for infection of skin,in minor cuts, scrapes, and burns
|adverseReactions=[[diarrhea]], [[nausea]], [[vomiting]]
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>


==Overview==
* Content


'''Neomycin''' is an [[aminoglycoside]] [[antibiotic]] that is found in many topical medications such as creams, ointments and eyedrops.
<!--Adult Indications and Dosage-->


==Category==
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Hepatic encephalopathy=====


Aminoglycoside
* Dosing Information


==US Brand Names==
:* 4 to 12 g/day ORALLY in divided doses for 5 to 6 days, maximum 12 g/day; do not use longer than 2 wks.


NEO-FRADIN<sup>®</sup>
=====Infection of skin, In minor cuts, scrapes, and burns; Prophylaxis=====


==FDA Package Insert==
* Dosing Information


'''  [[Neomycin description|Description]]'''
:* Apply small amount TOPICALLY to affected area not more than 2 to 3 times daily; may be covered with a sterile bandage.
'''| [[Neomycin clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Neomycin microbiology|Microbiology]]'''
'''| [[Neomycin indications and usage|Indications and Usage]]'''
'''| [[Neomycin contraindications|Contraindications]]'''
'''| [[Neomycin warnings and precautions|Warnings and Precautions]]'''
'''| [[Neomycin adverse reactions|Adverse Reactions]]'''
'''| [[Neomycin drug interactions|Drug Interactions]]'''
'''| [[Neomycin overdosage|Overdosage]]'''
'''| [[Neomycin clinical studies|Clinical Studies]]'''
'''| [[Neomycin dosage and administration|Dosage and Administration]]'''
'''| [[Neomycin how supplied|How Supplied]]'''
'''| [[Neomycin labels and packages|Labels and Packages]]'''


==Mechanism of Action==
=====Preparation of bowel for procedure, Preoperative; Adjunct=====


* Dosing Information


==Historical Perspective==
:* 1 g ORALLY 19, 18, and 9 hrs prior to surgery in combination with recommended bowel preparation regimen which includes erythromycin.


Neomycin was discovered in 1949 by the microbiologist [[Selman Waksman]] and his student Hubert Lechevalier. It is produced naturally by the bacterium ''Streptomyces fradiae''.
<!--Off-Label Use and Dosage (Adult)-->


==Uses==
<!--Guideline-Supported Use (Adult)-->
|offLabelAdultGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


Neomycin is overwhelmingly used as a [[topical]] preparation. It can also be given orally, where it is usually combined with other antibiotics. Neomycin is not absorbed from the gastrointestinal tract, and has been used as a preventative measure for [[hepatic encephalopathy]] and [[hypercholesterolemia]]. By killing bacteria in the intestinal tract, it keeps ammonia levels low and prevents hepatic encephalopathy, especially prior to GI surgery.  It has also been used to treat [[small intestinal bacterial overgrowth]].  It is not given intravenously, as neomycin is extremely [[nephrotoxic]] (causes [[kidney]] damage), especially compared to other [[aminoglycoside]]s. The exception to this, is when it is included in some vaccines as a preservative, but in very small quantities -typically 0.025 mg per dose[http://www.medscape.com/viewarticle/516045_6].
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


==Spectrum==
<!--Pediatric Indications and Dosage-->


Similar to other aminoglycosides, neomycin has excellent activity against [[Gram negative]] bacteria, and has partial activity against [[Gram positive]] bacteria.  It is relatively toxic to humans, and some people have allergic reactions to it.<ref>{{DermNet|dermatitis/neomycin-allergy}}</ref> See: [[Hypersensitivity]].
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Infection of skin, In minor cuts, scrapes, and burns; Prophylaxis=====


Neomycin is used in the [[medical laboratory|laboratory]] on [[agar]] plates to grow mutant forms of bacteria that carry genes for resistance to neomycin.  The resistant [[genes]] to neomycin are found within the [[plasmid]] of the bacteria; which may or may not be incorporated into the bacteria's circular [[chromosome]].
<!--Off-Label Use and Dosage (Pediatric)-->


==References==
<!--Guideline-Supported Use (Pediatric)-->
{{Reflist|2}}
|offLabelPedGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


[[Category:Antibiotics]]
<!--Non–Guideline-Supported Use (Pediatric)-->
[[Category:Wikinfect]]
|offLabelPedNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Contraindications-->
|contraindications=<!--Warnings-->
|warnings=*Warnings: For external use only.  Do not use: if you are allergic to any of the ingredients, in the eyes, over large areas of the body.  Ask a doctor before use if you have: large puncture wounds, animal bites, serious burns.
 
*Stop use and ask a doctor if: you need to use longer than one week, condition persists or gets worse, symptoms persist for more than one week or clear up and occur again within a few days, rash or other allergic reaction develops.
 
* Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away.
 
<!--Adverse Reactions-->
 
<!--Clinical Trials Experience-->
|drugInteractions=<!--Use in Specific Populations-->
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
 
* There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
 
<!--Administration and Monitoring-->
|administration=* Adults and children over 2 years of age or older: Clean the affected area.  Apply contents of packet to surface of affected area 2 times daily.  Gently rub in. Children under 2 years of age: Ask a doctor.
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 
<!--Overdosage-->
|drugBox=[[File:Neomycin wiki.png|600px|thumbnail|left]]
{{clear}}
|mechAction=*
 
<!--Structure-->
|structure=*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacokinetics-->
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 
<!--Nonclinical Toxicology-->
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 
<!--Clinical Studies-->
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 
<!--How Supplied-->
|howSupplied=*
|packLabel=[[File:Neomycin pdp.jpg|600px|thumbnail|left]]
{{clear}}
 
[[File:Neomycin label.png|600px|thumbnail|left]]
{{clear}}
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
 
<!--Precautions with Alcohol-->
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 
<!--Brand Names-->
|brandNames=Neo-Fradin
 
<!--Look-Alike Drug Names-->
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
|drugShortage=
}}
{{PillImage
|fileName=No image.jpg
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
<!--Pill Image-->
 
 
 
<!--Label Display Image-->
 
 
 
 
 
<!--Category-->
 
[[Category:Drug]]

Latest revision as of 19:33, 18 May 2015

Neomycin (topical)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Neomycin (topical) is an anti- bacterial agent, anti- infective agent that is FDA approved for the treatment of hepatic encephalopathy, preoperative preparation of bowel for procedure, prophylaxis for infection of skin,in minor cuts, scrapes, and burns. Common adverse reactions include diarrhea, nausea, vomiting.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Hepatic encephalopathy
  • Dosing Information
  • 4 to 12 g/day ORALLY in divided doses for 5 to 6 days, maximum 12 g/day; do not use longer than 2 wks.
Infection of skin, In minor cuts, scrapes, and burns; Prophylaxis
  • Dosing Information
  • Apply small amount TOPICALLY to affected area not more than 2 to 3 times daily; may be covered with a sterile bandage.
Preparation of bowel for procedure, Preoperative; Adjunct
  • Dosing Information
  • 1 g ORALLY 19, 18, and 9 hrs prior to surgery in combination with recommended bowel preparation regimen which includes erythromycin.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of Neomycin (topical) in adult patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of Neomycin (topical) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Infection of skin, In minor cuts, scrapes, and burns; Prophylaxis

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of Neomycin (topical) in pediatric patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of Neomycin (topical) in pediatric patients.

Contraindications

There is limited information regarding Neomycin (topical) Contraindications in the drug label.

Warnings

  • Warnings: For external use only. Do not use: if you are allergic to any of the ingredients, in the eyes, over large areas of the body. Ask a doctor before use if you have: large puncture wounds, animal bites, serious burns.
  • Stop use and ask a doctor if: you need to use longer than one week, condition persists or gets worse, symptoms persist for more than one week or clear up and occur again within a few days, rash or other allergic reaction develops.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Neomycin (topical) Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Neomycin (topical) Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Neomycin (topical) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Neomycin (topical) in women who are pregnant.
Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category
  • There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Neomycin (topical) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Neomycin (topical) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Neomycin (topical) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Neomycin (topical) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Neomycin (topical) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Neomycin (topical) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Neomycin (topical) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Neomycin (topical) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Neomycin (topical) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Neomycin (topical) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Neomycin (topical) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Adults and children over 2 years of age or older: Clean the affected area. Apply contents of packet to surface of affected area 2 times daily. Gently rub in. Children under 2 years of age: Ask a doctor.

Monitoring

There is limited information regarding Neomycin (topical) Monitoring in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Neomycin (topical) in the drug label.

Overdosage

There is limited information regarding Neomycin (topical) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

Mechanism of Action

Structure

File:Neomycin (topical)01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Neomycin (topical) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Neomycin (topical) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Neomycin (topical) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Neomycin (topical) in the drug label.

How Supplied

Storage

There is limited information regarding Neomycin (topical) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Neomycin (topical) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Neomycin (topical) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Neomycin (topical) in the drug label.

Precautions with Alcohol

  • Alcohol-Neomycin (topical) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Neo-Fradin

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Neomycin (topical)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Neomycin (topical)
 |Label Name=Neomycin (topical)11.png

}}

{{#subobject: 

 |Label Page=Neomycin (topical)
 |Label Name=Neomycin (topical)11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Neomycin_(topical)&oldid=1099221"